Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Invested Capital (2016 - 2025)

Historic Invested Capital for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $3.4 million.

  • Palisade Bio's Invested Capital fell 4783.6% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 4783.6%. This contributed to the annual value of $7.5 million for FY2024, which is 3460.2% down from last year.
  • Latest data reveals that Palisade Bio reported Invested Capital of $3.4 million as of Q3 2025, which was down 4783.6% from $2.7 million recorded in Q2 2025.
  • Palisade Bio's Invested Capital's 5-year high stood at $15.8 million during Q2 2023, with a 5-year trough of -$20.1 million in Q1 2021.
  • Its 5-year average for Invested Capital is $6.1 million, with a median of $7.0 million in 2024.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 30107.32% in 2021, then surged by 27520.78% in 2023.
  • Over the past 5 years, Palisade Bio's Invested Capital (Quarter) stood at $3.9 million in 2021, then skyrocketed by 218.34% to $12.5 million in 2022, then fell by 8.2% to $11.5 million in 2023, then tumbled by 34.6% to $7.5 million in 2024, then plummeted by 53.99% to $3.4 million in 2025.
  • Its Invested Capital stands at $3.4 million for Q3 2025, versus $2.7 million for Q2 2025 and $5.4 million for Q1 2025.